Skip to main content
TipRanks
Go Ultimate75% OFF

Keymed Biosciences, Inc. (2162) Balance Sheet

1 Followers

Keymed Biosciences, Inc. Balance Sheet

Keymed Biosciences, Inc.'s total assets for Q2 2026 were ¥5.67B, an increase of 34.35% from the previous quarter. HK:2162 total liabilities were ¥1.66B for the fiscal quarter, a 15.21% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
¥ 4.22B¥ 3.77B¥ 3.88B¥ 3.93B¥ 3.93B
¥ 1.44B¥ 1.29B¥ 896.11M¥ 593.10M¥ 289.07M
¥ 2.78B¥ 2.48B¥ 2.99B¥ 3.34B¥ 3.65B

Currency in CNY

Keymed Biosciences, Inc. Liabilities to Assets

01.5B3B4.5B0 %120 %240 %360 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets